Cisordinol (Zuclopenthixol)
First-generation antipsychotic for schizophrenia and psychotic disorders
Cisordinol (zuclopenthixol) is a first-generation (typical) antipsychotic medication belonging to the thioxanthene class. It is primarily prescribed for the treatment of schizophrenia and other psychotic disorders. Cisordinol works by blocking dopamine receptors in the brain, reducing symptoms such as hallucinations, delusions, thought disorders, anxiety, and agitation. This comprehensive guide covers indications, dosage, side effects, drug interactions, and important safety information based on international medical guidelines.
Quick Facts
Key Takeaways
- Cisordinol is a first-generation antipsychotic that blocks dopamine D1/D2 receptors to reduce psychotic symptoms such as hallucinations, delusions, and thought disorders.
- The usual adult dosage ranges from 10–50 mg daily, though higher doses may be needed. It is typically taken once daily, preferably in the evening due to its sedative effects.
- Common side effects include drowsiness, movement disorders (extrapyramidal symptoms), dry mouth, and restlessness. Most improve as treatment continues.
- Serious but rare risks include tardive dyskinesia, neuroleptic malignant syndrome, QT prolongation, and venous thromboembolism. Regular monitoring by a physician is essential.
- Cisordinol interacts with many medications including QT-prolonging drugs, tricyclic antidepressants, and levodopa. Always inform your doctor of all medications you take.
What Is Cisordinol and What Is It Used For?
Quick Answer: Cisordinol (zuclopenthixol) is a typical antipsychotic medication used to treat schizophrenia and other psychotic disorders. It reduces hallucinations, delusions, thought disturbances, and anxiety by blocking dopamine receptors in the brain.
Cisordinol contains the active substance zuclopenthixol, a thioxanthene derivative that belongs to the class of first-generation (typical) antipsychotic medications. It has been used in clinical psychiatry since the 1960s and remains an important treatment option for psychotic disorders worldwide. The medication is manufactured by H. Lundbeck A/S, a Danish pharmaceutical company specializing in central nervous system disorders.
As a neuroleptic medication, Cisordinol exerts its therapeutic effects primarily through dopamine D1 and D2 receptor antagonism in the brain. The mesolimbic dopamine pathway is particularly important for the antipsychotic effect, where excessive dopamine signaling is believed to contribute to positive psychotic symptoms. By reducing dopamine transmission in this pathway, Cisordinol helps alleviate hallucinations (hearing voices or seeing things that are not there), delusions (fixed false beliefs), and disorganized thinking.
In addition to its antipsychotic properties, zuclopenthixol also blocks serotonin 5-HT2 receptors and alpha-1 adrenergic receptors, which contribute to its anxiolytic (anxiety-reducing) and sedative effects. This makes Cisordinol particularly useful in patients who experience significant anxiety and agitation alongside their psychotic symptoms. The combined receptor profile provides broad symptom coverage for the complex presentations often seen in schizophrenia and related conditions.
Approved Indications
Cisordinol is approved for the treatment of:
- Schizophrenia – including both acute episodes and maintenance therapy to prevent relapse
- Other psychotic disorders – conditions characterized by hallucinations, delusions, or thought disturbances
- Acute psychotic agitation – when rapid calming is needed (particularly the depot/intramuscular formulations)
Zuclopenthixol may also be used off-label for other psychiatric conditions as determined by a treating physician. The decision to prescribe Cisordinol is based on a comprehensive psychiatric assessment that takes into account the specific symptom profile, severity, and individual patient factors. It is essential to follow your doctor's instructions and never use this medication for purposes other than those prescribed.
Cisordinol is available in multiple formulations internationally, including oral tablets, oral drops, and long-acting intramuscular depot injections (Cisordinol Depot / Clopixol Depot). This article focuses primarily on the oral tablet formulation. The medication is marketed under different brand names worldwide, including Clopixol in some countries.
What Should You Know Before Taking Cisordinol?
Quick Answer: Before taking Cisordinol, inform your doctor about all medical conditions, current medications, and whether you are pregnant or breastfeeding. Cisordinol is contraindicated in patients with alcohol/drug intoxication, certain blood disorders, and pheochromocytoma.
Before starting Cisordinol, a thorough medical evaluation is essential. Your prescribing physician needs to understand your complete medical history, current medications, and any relevant risk factors. This section outlines the key safety information you should discuss with your healthcare provider before beginning treatment.
Contraindications
You must not take Cisordinol if you:
- Are allergic to zuclopenthixol or any of the other ingredients in the medication (including lactose monohydrate, hydrogenated castor oil, potato starch, microcrystalline cellulose, copovidone, glycerol, talc, magnesium stearate, hypromellose, macrogol, titanium dioxide, or iron oxide)
- Are experiencing acute intoxication from alcohol, sedatives (sleeping pills), or strong analgesics (opioids such as morphine or similar substances)
- Have certain forms of blood disorders (haematological dyscrasias)
- Have a pheochromocytoma – a rare, usually benign tumor of the adrenal glands that produces excess catecholamines
Warnings and Precautions
Talk to your doctor or pharmacist before taking Cisordinol if any of the following apply to you:
- Liver impairment – The medication is metabolized by the liver, so reduced liver function may lead to higher blood levels and increased risk of side effects. Dose adjustments may be necessary.
- History of seizures or epilepsy – Antipsychotics, including zuclopenthixol, may lower the seizure threshold. Close monitoring and possible antiepileptic medication adjustments may be required.
- Brain damage – Particularly if caused by previous intoxication with alcohol or solvents, as this may increase sensitivity to the medication's effects.
- Risk factors for stroke – Including smoking, hypertension (high blood pressure), diabetes, atrial fibrillation, and history of transient ischemic attacks. Antipsychotics have been associated with an increased risk of cerebrovascular events, especially in elderly patients with dementia.
- Previous low white blood cell count (leukopenia) – Antipsychotics can affect white blood cell production. Regular blood monitoring may be recommended.
- History of cardiovascular disease or heart rhythm abnormalities – Zuclopenthixol may affect cardiac conduction and could prolong the QT interval in some patients.
- Use of other antipsychotic medications – Combining multiple antipsychotics increases the risk of side effects and requires careful medical supervision.
- Personal or family history of blood clots (venous thromboembolism) – Antipsychotic medications as a class have been associated with an increased risk of deep vein thrombosis and pulmonary embolism.
Movement disorders (extrapyramidal symptoms) such as tremor and muscle spasms may occur, particularly during the first days after starting treatment. Inform your doctor immediately, as the dose may need to be reduced. If you experience an irresistible need to move (akathisia), this can often be managed with appropriate medication. If you develop uncontrolled movements of the face and jaw (tardive dyskinesia), your treatment may need to be discontinued.
In very rare cases, antipsychotic medications can cause a life-threatening condition called neuroleptic malignant syndrome (NMS). Symptoms include high fever, unusual muscle stiffness, altered consciousness, sweating, and rapid heartbeat. If you experience these symptoms, seek emergency medical attention immediately and discontinue the medication.
Swallowing difficulties may occur as a secondary effect of extrapyramidal symptoms, drowsiness, increased saliva production, or neuroleptic malignant syndrome. If you experience difficulty swallowing, contact your physician promptly.
Dry mouth is a common side effect that, with long-term use, can lead to dental decay and damage to the oral mucosa. Careful dental hygiene with fluoride toothpaste twice daily is recommended. Regular dental check-ups are also advisable during long-term treatment.
Use in Children and Adolescents
Cisordinol is not recommended for use in children and adolescents. The safety and efficacy of zuclopenthixol in patients under 18 years of age have not been established. Pediatric patients requiring antipsychotic treatment should be managed by a child and adolescent psychiatrist who can select the most appropriate medication.
Pregnancy and Breastfeeding
If you are pregnant, think you may be pregnant, are planning to have a baby, or are breastfeeding, consult your doctor before using Cisordinol.
Pregnancy: Cisordinol should not be used during pregnancy unless it is absolutely necessary and the potential benefits clearly outweigh the risks to the fetus. Newborn babies exposed to antipsychotic medications during the third trimester of pregnancy may experience withdrawal symptoms including tremor, muscle stiffness or weakness, drowsiness, agitation, breathing problems, and feeding difficulties. If your baby develops any of these symptoms, contact a healthcare professional immediately.
Breastfeeding: Zuclopenthixol passes into breast milk, but at therapeutic doses it is unlikely to affect the nursing infant. However, consult your doctor before using Cisordinol during breastfeeding, particularly if using the medication for more than occasional or short-term purposes. Close monitoring of the infant for signs of excessive sedation is recommended.
Fertility: Cisordinol may affect fertility in both men and women. Elevated prolactin levels caused by the medication can potentially lead to menstrual irregularities, reduced libido, and erectile dysfunction. If you have concerns about fertility, discuss this with your prescribing physician.
Driving and Operating Machinery
Cisordinol may impair your ability to react quickly, which is important to consider when driving motor vehicles or operating precision machinery. The sedative effects are typically most pronounced at the start of treatment and following dose increases. You should not drive or operate machinery until you know how Cisordinol affects you. Discuss with your doctor or pharmacist if you are unsure about your fitness to drive.
Important Information About Excipients
Cisordinol tablets contain lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. The tablets also contain hydrogenated castor oil, which may cause stomach upset and diarrhea in some individuals.
How Does Cisordinol Interact with Other Drugs?
Quick Answer: Cisordinol interacts with many medications. Major interactions include QT-prolonging drugs, other antipsychotics, CNS depressants, and medications that affect dopamine signaling. Always inform your doctor about all medicines you take, including over-the-counter products.
Drug interactions can alter how Cisordinol works or increase the risk of serious side effects. It is critical to tell your doctor or pharmacist about all medications you are taking, have recently taken, or might take. This includes prescription medications, over-the-counter drugs, herbal products, and supplements.
Major Interactions (Avoid Combination)
The following medications should not be taken at the same time as Cisordinol due to the risk of serious or life-threatening interactions:
| Drug / Drug Class | Risk | Mechanism |
|---|---|---|
| QT-prolonging agents (quinidine, cisapride, moxifloxacin, erythromycin, mefloquine) | Cardiac arrhythmias, torsades de pointes | Additive QT-interval prolongation |
| Lithium | Neurotoxicity, increased extrapyramidal symptoms | Pharmacodynamic interaction |
| Methadone | QT prolongation, respiratory depression | Additive QT and CNS effects |
| Other antipsychotics | Increased side effects, excessive dopamine blockade | Pharmacodynamic overlap |
| Bromocriptine / Cabergoline | Mutual antagonism of therapeutic effects | Opposing dopaminergic actions |
| Codeine | Excessive CNS depression | Additive sedation and respiratory depression |
Moderate Interactions (Use with Caution)
The following medications require careful monitoring or dose adjustments when used concurrently with Cisordinol:
| Drug / Drug Class | Effect | Action |
|---|---|---|
| Tricyclic antidepressants | Increased plasma levels of both drugs | Monitor for increased side effects |
| Antihypertensives (blood pressure lowering drugs) | Excessive blood pressure drop (hypotension) | Monitor blood pressure regularly |
| Barbiturates and similar sedatives | Enhanced sedation and CNS depression | Reduce doses if needed |
| Antiepileptic drugs | Altered seizure threshold, changed drug levels | Monitor seizure control and drug levels |
| Levodopa and dopamine agonists | Reduced antiparkinsonian effect | Avoid combination if possible |
| Metoclopramide | Increased extrapyramidal side effects | Avoid combination |
| Piperazine (anthelmintic) | Increased risk of extrapyramidal effects | Monitor for movement disorders |
| Thiazide diuretics | Electrolyte imbalances (low potassium/magnesium) increasing arrhythmia risk | Monitor electrolytes regularly |
| CYP2D6/CYP3A4 inhibitors | Increased zuclopenthixol plasma levels | May require dose reduction |
Alcohol
Cisordinol can be taken with or without food. However, alcohol should be avoided during treatment. Alcohol significantly enhances the sedative effects of Cisordinol, potentially leading to excessive drowsiness, impaired judgment, reduced coordination, and increased risk of falls. The combination may also increase the risk of respiratory depression. Even moderate alcohol consumption is inadvisable during Cisordinol therapy.
What Is the Correct Dosage of Cisordinol?
Quick Answer: The usual adult dose of Cisordinol is 10–50 mg per day, taken once daily (preferably in the evening). Dosing varies significantly depending on the individual and the condition being treated. Always follow your doctor's instructions.
Always take Cisordinol exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. The dosage is individually determined based on the severity of symptoms, treatment response, and tolerability. Your doctor will typically start with a lower dose and gradually increase it to find the optimal therapeutic dose.
Adults
Standard Adult Dosage
The usual dosage is 10–50 mg per day. However, substantially higher doses may be necessary in some cases depending on the clinical situation. Dosing varies considerably depending on the type and severity of the condition being treated.
Cisordinol tablets are usually taken once daily, preferably in the late afternoon or evening, as the medication can cause drowsiness. Swallow the tablets whole with a glass of water. The tablets can be taken with or without food.
Elderly Patients
Elderly Dosage
Elderly patients should be given doses in the lower end of the dosing range. Older adults are generally more sensitive to the effects and side effects of antipsychotic medications, including orthostatic hypotension (blood pressure drops upon standing), sedation, and extrapyramidal symptoms. Careful dose titration and regular monitoring are essential in this population.
Children
Pediatric Use
Cisordinol is not recommended for children and adolescents under 18 years of age. Safety and efficacy have not been established in this population.
| Patient Group | Recommended Dose | Administration | Notes |
|---|---|---|---|
| Adults | 10–50 mg/day (higher if needed) | Once daily, evening preferred | Titrate gradually based on response |
| Elderly | Lower end of range | Once daily, evening preferred | More sensitive to side effects; monitor closely |
| Children (<18 years) | Not recommended | N/A | Safety and efficacy not established |
| Hepatic impairment | Reduced dose | Once daily | Monitor liver function; slower metabolism |
Missed Dose
If you forget to take a dose of Cisordinol, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose and take the next one at the regular time. Do not take a double dose to make up for a forgotten tablet. If you are unsure what to do, consult your doctor or pharmacist.
Overdose
If you have taken too much Cisordinol, or if a child has accidentally ingested the medication, contact your doctor, hospital emergency department, or poison control center immediately. Do this even if there are no noticeable symptoms. In overdose, side effects may become more pronounced, and symptoms may include reduced consciousness, breathing difficulties, rapid heartbeat (tachycardia), seizures, severe hypotension, and extrapyramidal symptoms.
- The full antipsychotic effect may not be apparent until several weeks of treatment. Do not discontinue the medication prematurely.
- The duration of treatment is determined in consultation with your doctor. Do not stop treatment without first consulting your physician.
- Abrupt discontinuation may cause withdrawal symptoms including nausea, vomiting, insomnia, and return of psychotic symptoms.
- Dose reductions should always be done gradually under medical supervision.
What Are the Side Effects of Cisordinol?
Quick Answer: The most common side effects of Cisordinol include drowsiness, restlessness, movement disorders, and dry mouth. Serious but rare effects include tardive dyskinesia, neuroleptic malignant syndrome, and cardiac arrhythmias. Most side effects are most pronounced at the start of treatment.
Like all medicines, Cisordinol can cause side effects, although not everybody gets them. Many side effects are most noticeable during the first days and weeks of treatment and tend to diminish as your body adjusts to the medication. Your doctor will monitor you for side effects and adjust your treatment if necessary.
Contact your doctor or go to the nearest hospital emergency department immediately if you experience: high fever with unusual muscle stiffness and altered consciousness (possible neuroleptic malignant syndrome); uncontrolled movements of the mouth and tongue (possible tardive dyskinesia); signs of a severe allergic reaction (difficulty breathing, swelling of face/throat); yellowing of skin and eyes (jaundice); sudden severe headache, chest pain, or difficulty breathing with leg swelling (possible blood clot).
Very Common
May affect more than 1 in 10 people
- Drowsiness (somnolence)
- Restlessness and inability to sit still (akathisia)
- Involuntary movements (hyperkinesia)
- Slow or reduced movements (hypokinesia)
- Dry mouth
- Extrapyramidal symptoms (tremor, muscle spasms, movement disorders)
Common
May affect up to 1 in 10 people
- Rapid heartbeat (tachycardia), palpitations
- Tremor, dystonia (abnormal muscle tone), hypertonia (increased muscle stiffness)
- Dizziness, headache, tingling/numbness (paraesthesia)
- Impaired attention, memory problems (amnesia), gait disturbance
- Visual disturbances, difficulty focusing (accommodation disorder)
- Nasal congestion, breathing difficulties (dyspnoea)
- Increased salivation, constipation, vomiting, indigestion (dyspepsia), diarrhea
- Urination difficulties (micturition disorders), urinary retention, increased urine output
- Increased sweating (hyperhidrosis), itching (pruritus)
- Muscle pain (myalgia)
- Increased appetite, weight gain
- Fatigue, weakness (asthenia), general malaise, pain
- Insomnia, depression, anxiety, nervousness, abnormal dreams, agitation, decreased libido
Uncommon
May affect up to 1 in 100 people
- Tardive dyskinesia (unusual movements of mouth and tongue)
- Hyperactive reflexes, dyskinesia, parkinsonism, fainting (syncope)
- Lack of coordination (ataxia), speech difficulties, reduced muscle tone, seizures, migraine
- Eye-rolling (oculogyration), dilated pupils (mydriasis)
- Sound sensitivity (hyperacusis), ringing in ears (tinnitus)
- Abdominal pain, nausea, flatulence
- Rash, photosensitivity, pigmentation disorders, oily skin (seborrhoea), eczema, dermatitis, purpura
- Muscle rigidity, lockjaw (trismus), neck twisting (torticollis)
- Decreased appetite, weight loss
- Low blood pressure (hypotension), hot flushes
- Thirst, abnormally low body temperature (hypothermia), fever
- Abnormal liver function tests
- Sexual dysfunction (ejaculation failure, erectile dysfunction, orgasm difficulties, vaginal dryness)
- Apathy, nightmares, increased libido, confusion
Rare
May affect up to 1 in 1,000 people
- Swallowing difficulties (dysphagia)
- Low platelet count (thrombocytopenia)
- Low white blood cell count (neutropenia, leukopenia)
- Elevated prolactin levels (hyperprolactinaemia)
- High blood sugar (hyperglycaemia), impaired glucose tolerance, elevated blood lipids (hyperlipidaemia)
- Hypersensitivity reactions, anaphylactic reaction
- Breast enlargement in men (gynaecomastia), excessive milk production (galactorrhoea)
- Absent menstruation (amenorrhoea), persistent painful erection (priapism)
- Agranulocytosis (severe reduction in white blood cells leading to impaired infection defense)
Very Rare
May affect up to 1 in 10,000 people
- Neuroleptic malignant syndrome (NMS) – high fever, severe muscle stiffness, altered consciousness, sweating, rapid heartbeat
- Jaundice (yellowing of skin and eyes indicating liver involvement)
- Blood clots (venous thromboembolism) – deep vein thrombosis, pulmonary embolism
- QT prolongation (abnormal heart rhythm on ECG)
- Ventricular arrhythmias, ventricular fibrillation, ventricular tachycardia
- Torsades de pointes (a specific type of dangerous heart rhythm)
- Cardiac arrest
Blood clots, particularly in the legs (symptoms include swelling, pain, and redness), may travel to the lungs causing chest pain and breathing difficulties (pulmonary embolism). If you experience any of these symptoms, seek immediate medical attention. Immobility, obesity, and a personal or family history of blood clots may increase this risk.
A small increase in the number of deaths has been reported among elderly people with dementia who are treated with antipsychotic medications compared to those who do not receive such treatment. Antipsychotics are generally not recommended as first-line treatment for behavioral symptoms in dementia, and their use in this population requires careful risk-benefit assessment.
How Should You Store Cisordinol?
Quick Answer: Store Cisordinol out of the sight and reach of children. The 2 mg tablets should be stored in the original packaging and protected from light. Use before the expiry date. Do not dispose of medications via household waste or wastewater.
Proper storage of medications is essential to maintain their effectiveness and safety. Follow these guidelines for storing Cisordinol tablets:
- Keep this medicine out of the sight and reach of children.
- Do not use after the expiry date printed on the label. The expiry date refers to the last day of the stated month.
- 2 mg tablets: Store in the original packaging. Light-sensitive – keep protected from light at all times.
- 10 mg and 25 mg tablets: No special storage conditions required.
- Store at room temperature below 25°C (77°F) unless otherwise directed.
- Do not dispose of medications via household waste or down the drain. Return unused medications to your pharmacy for proper environmental disposal.
What Does Cisordinol Contain?
Quick Answer: The active substance is zuclopenthixol dihydrochloride (equivalent to 2 mg, 10 mg, or 25 mg zuclopenthixol per tablet). Excipients include potato starch, lactose monohydrate, microcrystalline cellulose, and various coating agents.
Understanding the full composition of your medication is important, particularly if you have known allergies or intolerances. Below is the complete list of ingredients in Cisordinol tablets:
Active Substance
Zuclopenthixol dihydrochloride, equivalent to 2 mg, 10 mg, or 25 mg of zuclopenthixol per tablet respectively.
Inactive Ingredients (Excipients)
The other ingredients are:
- Tablet core: Potato starch, lactose monohydrate, microcrystalline cellulose, copovidone, glycerol (85%), talc, hydrogenated castor oil, magnesium stearate
- Film coating: Hypromellose, macrogol, titanium dioxide (E171), iron oxide (E172)
Patients with lactose intolerance should be aware that each tablet contains lactose monohydrate. The hydrogenated castor oil may cause gastrointestinal discomfort in some individuals. If you have any known allergies to the above ingredients, consult your doctor before taking Cisordinol.
Marketing Authorisation Holder and Manufacturer
H. Lundbeck A/S
Ottiliavej 9, 2500 Valby, Denmark
Cisordinol is marketed internationally under various brand names including Clopixol in some regions. The medication has been available since the 1960s and is registered in numerous countries worldwide.
Frequently Asked Questions About Cisordinol
Cisordinol (zuclopenthixol) is a first-generation antipsychotic medication primarily used to treat schizophrenia and other psychotic disorders. It works by blocking dopamine D1 and D2 receptors in the brain, which helps reduce psychotic symptoms such as hallucinations (hearing voices or seeing things), delusions (fixed false beliefs), and thought disorders. It also has anxiolytic (anti-anxiety) and calming effects, making it particularly useful for patients who experience significant anxiety and agitation alongside their psychotic symptoms.
The most common side effects (affecting more than 1 in 10 people) include drowsiness, restlessness (akathisia), involuntary movements, slow movements, dry mouth, and extrapyramidal symptoms such as tremor and muscle spasms. Common side effects (up to 1 in 10 people) include rapid heartbeat, dizziness, headache, constipation, weight gain, fatigue, insomnia, and anxiety. Most of these side effects are most pronounced at the beginning of treatment and tend to diminish over time.
No, you should avoid alcohol while taking Cisordinol. Alcohol significantly enhances the sedative effects of the medication, leading to excessive drowsiness, impaired coordination, reduced alertness, and increased risk of falls. The combination can also increase the risk of respiratory depression. If you have concerns about social situations where alcohol may be present, discuss strategies with your doctor or pharmacist.
Cisordinol may provide some sedative and anxiolytic effects within the first few days of treatment. However, the full antipsychotic effect – particularly against core symptoms like hallucinations and delusions – typically develops over several weeks of consistent use. It is very important to continue taking the medication as prescribed even if you do not notice immediate improvement in your symptoms. Your doctor will assess your progress and adjust the dose as needed over time.
Cisordinol should not be used during pregnancy unless the potential benefits clearly outweigh the risks. Newborns exposed to antipsychotics during the third trimester may experience withdrawal symptoms including tremor, muscle stiffness or weakness, drowsiness, agitation, breathing problems, and feeding difficulties. If you discover you are pregnant while taking Cisordinol, do not stop the medication abruptly – contact your doctor as soon as possible to discuss the safest approach. Abrupt discontinuation could be harmful to both you and your baby.
If you miss a dose, take it as soon as you remember unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular schedule. Never take a double dose to compensate. If you frequently forget doses, ask your doctor or pharmacist about strategies to help you remember, such as setting alarms or using a pill organizer. Consistent daily dosing is important for maintaining the therapeutic effect of the medication.
References
This article is based on the following peer-reviewed and authoritative medical sources:
- European Medicines Agency (EMA). Zuclopenthixol – Summary of Product Characteristics (SmPC). EMA Product Information Database. Available at: www.ema.europa.eu
- World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd List (2023). Geneva: World Health Organization; 2023.
- British National Formulary (BNF). Zuclopenthixol. National Institute for Health and Care Excellence (NICE). Available at: bnf.nice.org.uk
- National Institute for Health and Care Excellence (NICE). Psychosis and schizophrenia in adults: prevention and management. Clinical guideline [CG178]. Updated March 2014. Available at: www.nice.org.uk/guidance/cg178
- Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382(9896):951-962. doi:10.1016/S0140-6736(13)60733-3
- Stroup TS, Gray N. Management of common adverse effects of antipsychotic medications. World Psychiatry. 2018;17(3):341-356. doi:10.1002/wps.20567
- Huhn M, Nikolakopoulou A, Schneider-Thoma J, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019;394(10202):939-951. doi:10.1016/S0140-6736(19)31135-3
- American Psychiatric Association. Practice Guideline for the Treatment of Patients With Schizophrenia. 3rd ed. Washington, DC: American Psychiatric Association; 2021.
- Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs. 2004;64(20):2291-2314. doi:10.2165/00003495-200464200-00003
- Correll CU, Rubio JM, Kane JM. What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia? World Psychiatry. 2018;17(2):149-160. doi:10.1002/wps.20516
Medical Editorial Team
This article has been written and reviewed by our medical editorial team consisting of licensed physicians specializing in psychiatry and psychopharmacology. All content follows the GRADE evidence framework and adheres to international medical guidelines from WHO, EMA, NICE, and the American Psychiatric Association.
- Evidence Level 1A (systematic reviews and RCTs)
- Peer-reviewed by board-certified psychiatrists
- Updated according to latest clinical guidelines
- No commercial funding or pharmaceutical sponsorship
- Initial draft by specialist physician
- Medical accuracy review by second physician
- Patient readability assessment
- Regular updates based on new evidence
Last medical review:
Next scheduled review: